Powered by:


Micrometric and nanometric beads for biological and chemical applications

The Company, born in 2014 and managed by a young team of PhD's ("Doctors on Phylosophy") with academic experience in Biomolecular Science and Material Chemistry, is located in a scientific science park.
Type of beads and uses are as follows.

1) Silica nanospheres with diameter ranging from 30 nm to 500 nm, and available with bare and amine-terminated surfaces. Multiple sizes (up to 2.6 m), surfaces and larger quantities (up to 5 g) are available as a custom request.

Uses: biological separations/functionalization, drug delivery, Imaging.

2) Magnetic agarose beads functionalized with avidin, protein A, protein G or both of them. Average particle size: 50 m.

Uses: Immunoprecipitation & Co-Immunoprecipitation Assay.

3) Gold colloid nanoparticles with dimensions ranging from 17 to 23 nm.

Uses: Raman Spectroscopy, Imaging, Thiol chemistry.

4) Magnetic beads coated with a gold shell, which are subsequently functionalized to bind molecules of biological interest.

Uses: Biological separation, thiol chemistry, Raman spectroscopy.

5) Star-shaped gold nanoparticles with dimensions ranging from 40 to 150 nm.

Uses: Raman Spectroscopy, Imaging, Thiol chemistry.

6) Particles for catalysis and toxic dye adsorbtion

User: Faster and more efficient catalysis.

The company is looking for distributors belonging to industry and specialised in biotech and chemical products.

The distributor shall put in its portfolio the beads (micro and nano metric) and distribute them to labs, chemical industries, hospitals, etc.

» Reference: BOIT20170829001/ITALY

» Sector: Ciencias de la vida Manufactura Industrial Medio Ambiente Industria

» More Information

« Go to Technological Watch


[17/09/2018] - Primex Color & Compounding Opens Customer Solutions Center

[17/09/2018] - CFRP employed in oil control valve

[17/09/2018] - Fairprene know-how drives recent Trelleborg expansions

[17/09/2018] - ABB and Nobel Media announce international partnership

This project has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n [310187].